n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with guanabenz in 1 studies
| Studies (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Trials (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Recent Studies (post-2010) (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Studies (guanabenz) | Trials (guanabenz) | Recent Studies (post-2010) (guanabenz) |
|---|---|---|---|---|---|
| 214 | 5 | 58 | 446 | 42 | 96 |
| Protein | Taxonomy | n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine (IC50) | guanabenz (IC50) |
|---|---|---|---|
| trace amine-associated receptor 1 | Homo sapiens (human) | 1.173 | |
| Solute carrier family 22 member 1 | Homo sapiens (human) | 4.85 | |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.204 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.041 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.149 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 1.106 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 2.068 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 1.787 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.472 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.392 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.204 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 2.068 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.097 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, FE; Legname, G; May, BC; Prusiner, SB; Sherrill, J; Wallace, AC; Witkop, J; Zorn, JA | 1 |
1 other study(ies) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and guanabenz
| Article | Year |
|---|---|
Structure-activity relationship study of prion inhibition by 2-aminopyridine-3,5-dicarbonitrile-based compounds: parallel synthesis, bioactivity, and in vitro pharmacokinetics.
Topics: Aminopyridines; Animals; Cell Line, Tumor; Combinatorial Chemistry Techniques; Membranes, Artificial; Mice; Models, Molecular; Nitriles; Permeability; PrPSc Proteins; Solubility; Structure-Activity Relationship | 2007 |